[
Pelthos Therapeutics to restate Q1 2026 financials due to convertible debt valuation
[og_img]
https://www.investing.com/news/sec-filings/pelthos-therapeutics-to-restate-q1-2026-financials-due-to-convertible-debt-valuation-93CH-4857376
Investing.com
Pelthos Therapeutics to restate Q1 2026 financials due to convertible debt valuation
Related articles
